Study Finds That Surgical Protocols May Have Greater Impact on Survival Times Than Designated Stage

A new report out of Belgium, published in the Acta Chirugica Belgica studied 101 pleural mesothelioma cases from 2001 to 2015. The study found that the median survival time of 18.3 months. Of the cases studied the survival rates were as follows:

  • After 1 Year: 68% of patients were still living
  • After 2 Years: 37% of patients were still living
  • After 5 Years: 7% of patients were still living

Understanding the TNH system

The staging system is designed for predict outcomes and select treatment protocols based on three factors:

  • T – Original tumor size
  • N- level of lymph node involvement
  • M- Metastases or spread of the cancer

Surgery Versus The Staging System

The results of the study points to the idea that the stage alone may have negligible impact on survival rates. The author of the study reported that “A significant difference in survival was observed in patients undergoing surgery versus no surgery…and treatment with chemotherapy alone versus chemotherapy with surgery.” One of the other significant factors for survival times was whether the patient was a smoker. Smoker tended to have worse treatment outcomes.

The Paul Law Firm advocates for victims of asbestos-related diseases. If you or a loved one is suffering from mesothelioma, call the Paul Law Firm. With over 2.5 billion dollars collected for victims of asbestos exposure, we have the knowledge and the experience to fight for you. We also understand that fighting doesn’t just happen in the courtroom. It also happens in a lab where we are fighting for a cure. Check out the Mesothelioma Research Foundation of America here.

Call us today at 1-855 88 LEGAL (885-3425) or contact us online to discuss your case with one of our experienced mesothelioma lawyers